1,1'-Carbonyldiimidazole → (3S)-N-(3-((2-chloro-5-fluoropyrimidin-4-yl)amino)-5-methylcyclohexyl)-3-fluoropyrrolidine-1-carboxamide
反応式
[Cl:1][C:2]1[N:7]=[C:6]([NH:8][CH:9]2[CH2:14][CH:13]([CH3:15])[CH2:12][CH:11]([NH2:16])[CH2:10]2)[C:5]([F:17])=[CH:4][N:3]=1.[C:18](N1C=CN=C1)(N1C=CN=C1)=[O:19].CCN(C(C)C)C(C)C.Cl.[F:40][C@H:41]1[CH2:45][CH2:44][NH:43][CH2:42]1>C1COCC1>[Cl:1][C:2]1[N:7]=[C:6]([NH:8][CH:9]2[CH2:14][CH:13]([CH3:15])[CH2:12][CH:11]([NH:16][C:18]([N:43]3[CH2:44][CH2:45][C@H:41]([F:40])[CH2:42]3)=[O:19])[CH2:10]2)[C:5]([F:17])=[CH:4][N:3]=1参加物
6
反応物 4
生成物 1
試薬・触媒・溶媒 1
実験手順
To a solution of N1-(2-chloro-5-fluoropyrimidin-4-yl)-5-methylcyclohexane-1,3-diamine, 76b, (0.14 g. 0.54 mmol) in THF (2.5 ml) was added carbonyldiimidazole (0.10 g, 0.60 mmol) and iPr2NEt (0.28 mL, 1.62 mmol). The reaction was aged 2 hours at room temp, and treated with (S)-3-fluoropyrrolidine hydrochloride (0.07 g, 0.54 mmol). The reaction was stirred at room temperature for 2 days and then concentrated to dryness to afford 202 mg of (3S)—N-(3-((2-chloro-5-fluoropyrimidin-4-yl)amino)-5-methylcyclohexyl)-3-fluoropyrrolidine-1-carboxamide which was used without purification: LCMS RT=2.46 (M+1) 374.2, (M−1) 372.
後処理
- concentrationconcentrated to dryness
出典と根拠
- ORDレコード
- ord-419d09ac130d4691be69c1166f9b7b44
- 出典データセット
- uspto-grants-2014_09
- 特許番号
- US08829007B2
反応ノート
読み込み中…